scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VACCINE.2011.03.028 |
P698 | PubMed publication ID | 21440035 |
P50 | author | Francisco J. Salguero | Q40256272 |
Mark Chambers | Q53342381 | ||
Dipesh Davé | Q57160086 | ||
Timothy Crawshaw | Q57160094 | ||
Alejandro Nunez | Q57394149 | ||
P2093 | author name string | R Glyn Hewinson | |
Si Palmer | |||
Sandrine Lesellier | |||
Leigh A L Corner | |||
Ute Weyer | |||
Roland Ashford | |||
Deanna Dalley | |||
Sonya Gowtage-Sequiera | |||
P2860 | cites work | A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10) | Q28487601 |
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research | Q29547313 | ||
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection | Q29616521 | ||
The duration of the effects of repeated widespread badger culling on cattle tuberculosis following the cessation of culling | Q33531786 | ||
Field evaluation of the efficacy of Mycobacterium bovis bacillus Calmette-Guerin against bovine tuberculosis in neonatal calves in Ethiopia | Q34190004 | ||
M. tuberculosis: immunology and vaccination | Q34281159 | ||
Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeats | Q34470358 | ||
Vaccinating badgers (Meles meles) against Mycobacterium bovis: the ecological considerations | Q35145959 | ||
Identification of immune response correlates for protection against bovine tuberculosis | Q36248313 | ||
Tuberculosis: the disease and its epidemiology in the badger, a review | Q36473261 | ||
Mycobacterium bovis in the European badger (Meles meles): epidemiological findings in tuberculous badgers from a naturally infected population | Q36503379 | ||
Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves | Q37360027 | ||
Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. | Q39655276 | ||
Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guèrin induced protection against Mycobacterium bovis | Q40396473 | ||
The efficacy of bacille Calmette-Guérin vaccine in wild brushtail possums (Trichosurus vulpecula). | Q40636727 | ||
Experimental tuberculosis in the European badger (Meles meles) after endobronchial inoculation with Mycobacterium bovis: II. Progression of infection | Q43815405 | ||
Tuberculosis in wild badgers in Gloucestershire: epidemiology | Q43820325 | ||
Lipid-formulated bcg as an oral-bait vaccine for tuberculosis: vaccine stability, efficacy, and palatability to brushtail possums (Trichosurus vulpecula) in New Zealand | Q44119303 | ||
Leukocyte coping capacity: a novel technique for measuring the stress response in vertebrates | Q44513450 | ||
Vaccination of the brushtail possum (Trichosurus vulpecula) against Mycobacterium bovis infection with bacille Calmette-Guérin: the response to multiple doses. | Q44658708 | ||
Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations | Q46318328 | ||
Impacts of widespread badger culling on cattle tuberculosis: concluding analyses from a large-scale field trial. | Q51102582 | ||
Bacillus Calmette-Guérin vaccination reduces the severity and progression of tuberculosis in badgers. | Q54394183 | ||
The prevalence, distribution and severity of detectable pathological lesions in badgers naturally infected with Mycobacterium bovis | Q56830785 | ||
Oral vaccination reduces the incidence of tuberculosis in free-living brushtail possums | Q58433112 | ||
PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis | Q58779416 | ||
The impact of badger removal on the control of tuberculosis in cattle herds in Ireland | Q59626123 | ||
Vaccination of white-tailed deer (Odocoileus virginianus) with Mycobacterium bovis bacillus Calmette Guerín | Q60130165 | ||
Vaccine protocols to optimise the protective efficacy of BCG | Q73403328 | ||
The effects of inadvertent intramuscular injection of BCG vaccine | Q74193116 | ||
Oral vaccination of brushtail possums with BCG: Investigation into factors that may influence vaccine efficacy and determination of duration of protection | Q79210515 | ||
Experimental tuberculosis in the European badger (Meles meles) after endobronchial inoculation of Mycobacterium bovis: I. Pathology and bacteriology | Q79464950 | ||
Comparison of a standard and a detailed postmortem protocol for detecting Mycobacterium bovis in badgers | Q79640865 | ||
Development and evaluation of a gamma-interferon assay for tuberculosis in badgers (Meles meles) | Q80206613 | ||
Influence of stress of capture on haematological values and cellular immune responses in the Australian brushtail possum (Trichosurus vulpecula) | Q80399102 | ||
Vaccination of European badgers (Meles meles) with BCG by the subcutaneous and mucosal routes induces protective immunity against endobronchial challenge with Mycobacterium bovis | Q81245870 | ||
Survey of badger access to farm buildings and facilities in relation to contact with cattle | Q81705703 | ||
Immunological responses and protective immunity in BCG vaccinated badgers following endobronchial infection with Mycobacterium bovis | Q82612237 | ||
The safety and immunogenicity of Bacillus Calmette-Guérin (BCG) vaccine in European badgers (Meles meles) | Q83315390 | ||
Oral vaccination of badgers (Meles meles) with BCG and protective immunity against endobronchial challenge with Mycobacterium bovis | Q84574902 | ||
P433 | issue | 21 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | tuberculosis | Q12204 |
Eurasian Badger | Q27066 | ||
P304 | page(s) | 3782-3790 | |
P577 | publication date | 2011-04-07 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Protection of Eurasian badgers (Meles meles) from tuberculosis after intra-muscular vaccination with different doses of BCG | |
P478 | volume | 29 |
Q91306753 | A combined measure of tuberculous lesions for assessing the efficacy of vaccination against tuberculosis (Mycobacterium bovis) in European badgers (Meles meles) supports the 3Rs principle of reduction |
Q46854258 | Association of quantitative interferon-γ responses with the progression of naturally acquired Mycobacterium bovis infection in wild European badgers (Meles meles). |
Q27335059 | BCG vaccination reduces risk of tuberculosis infection in vaccinated badgers and unvaccinated badger cubs |
Q58570259 | Bait uptake by wild badgers and its implications for oral vaccination against tuberculosis |
Q37985287 | Bovine tuberculosis vaccine research: historical perspectives and recent advances. |
Q91763455 | Detection of live M. bovis BCG in tissues and IFN-γ responses in European badgers (Meles meles) vaccinated by oropharyngeal instillation or directly in the ileum |
Q58707232 | Efficacy and Safety of BCG Vaccine for Control of Tuberculosis in Domestic Livestock and Wildlife |
Q53342281 | Evaluation of a method to detect Mycobacterium bovis in air samples from infected Eurasian badgers (Meles meles) and their setts. |
Q56933186 | Exposure of nontarget wildlife to candidate TB vaccine baits deployed for European badgers |
Q38687859 | Field evaluation of candidate baits for oral delivery of BCG vaccine to European badgers, Meles meles |
Q50507396 | Histological and immunohistochemical characterisation of Mycobacterium bovis induced granulomas in naturally infected fallow deer (Dama dama). |
Q51211568 | Modelling the impact of vaccination on tuberculosis in badgers. |
Q64244499 | New serological platform for detecting antibodies against Mycobacterium tuberculosis complex in European badgers |
Q50487971 | Non-tuberculous mycobacteria in wild boar (Sus scrofa) from Southern Spain: epidemiological, clinical and diagnostic concerns. |
Q36259625 | Oral Vaccination of Free-Living Badgers (Meles meles) with Bacille Calmette Guérin (BCG) Vaccine Confers Protection against Tuberculosis |
Q38639732 | Oral Vaccination with Heat-Inactivated Mycobacterium bovis Does Not Interfere with the Antemortem Diagnostic Techniques for Tuberculosis in Goats. |
Q38156497 | Overview of vaccination trials for control of tuberculosis in cattle, wildlife and humans |
Q89967850 | Protective Effect of Oral BCG and Inactivated Mycobacterium bovis Vaccines in European Badgers (Meles meles) Experimentally Infected With M. bovis |
Q64101220 | Survival of Mycobacterium bovis BCG oral vaccine during transit through a dynamic in vitro model simulating the upper gastrointestinal tract of badgers |
Q28602294 | Tackling tuberculosis: Insights from an international TB Summit in London |
Q39026432 | Testing of a palatable bait and compatible vaccine carrier for the oral vaccination of European badgers (Meles meles) against tuberculosis |
Q37601369 | The Effect of Oral Vaccination with Mycobacterium bovis BCG on the Development of Tuberculosis in Captive European Badgers (Meles meles). |
Q55113282 | Veterinary and human vaccine evaluation methods. |
Search more.